PHAT (PHAT) Price Target

Track Wall Street analyst price targets and coverage changes.

Consensus Price Target

$18.00

▲ 333.7% Upside
based on current price $4.15
High Target
$18.00
Median Target
$18.00
Low Target
$18.00
Analyst Coverage
Last Month
0
$0.00
Last Quarter
1
$18.00
Last Year
4
$20.50
Individual Price Targets
$28$28$21$21$14$14$7$7$0$0Price Target ($)May 2May 2Jul 3Jul 3Sep 3Sep 3Nov 4Nov 4Jan 4Jan 4DateCurrent Price: $4.15Consensus: $18.00
Latest Analyst Coverage
Date Analyst Firm Target Price When Posted Upside News
Mar 07, 2025 Guggenheim $18.00 $5.06 255.7% Phathom Pharmaceuticals price target lowered to $18 from $28 at Guggenheim
Aug 08, 2024 Paul Choi Goldman Sachs $12.00 $11.75 2.1% Phathom Pharmaceuticals (PHAT) PT Raised to $12 at Goldman Sachs
Jul 19, 2024 Matthew Caufield H.C. Wainwright $28.00 $10.95 155.8% H.C. Wainwright Reiterates Buy Rating on Phathom Pharmaceuticals (PHAT)
May 02, 2024 Annabel Samimy Stifel Nicolaus $24.00 $9.76 145.9% Phathom Pharmaceuticals initiated with a Buy at Stifel

Related Metrics

Explore detailed financial metrics and analysis for PHAT.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio